Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3006 Target Snapshot

5-hydroxytryptamine receptor 2C · SINGLE PROTEIN · Mus musculus

15Compounds
9Assays
2Approved Drugs
12.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P34968. Use UniProt P34968 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P34968 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 2C as ChEMBL target CHEMBL3006, mapped to UniProt P34968. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 2C
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL3006
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P34968
5-hydroxytryptamine receptor 2C
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 2C is the right protein anchor across sources, using UniProt P34968 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 2C
UniProt AccessionP34968
Component TypeProtein
Sequence Length459 aa

5-hydroxytryptamine receptor 2C

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 2C, mapped to UniProt P34968. Sequence length is 459 aa.

Mapped IDP34968
Review name5-hydroxytryptamine receptor 2C
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

KI12.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL297784 8.0 Ki 10.0 Preclinical
CHEMBL516 7.96 Ki 11.0 Approved
CHEMBL47482 7.37 Ki 43.0 Preclinical
CHEMBL85194 6.86 Ki 138.04 Preclinical
CHEMBL11 6.8 Ki 160.0 Approved
CHEMBL3942898 5.96 Ki 1108.0 Preclinical
CHEMBL323356 5.82 Ki 1513.56 Preclinical
CHEMBL3946540 5.47 Ki 3386.0 Preclinical
CHEMBL3986651 5.42 Ki 3763.0 Preclinical
CHEMBL4112412 5.2 Ki 6374.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
2
5.5
0
6.0
2
6.5
1
7.0
1
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CYPROHEPTADINE
CHEMBL516
Approved 1961
IMIPRAMINE
CHEMBL11
Approved 1959
Assay Landscape

Assay Landscape

9
Total Assays
11
Tested Compounds
2
Assay Types
Binding — 7 assays, 11 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 3 7.4
tissue-based format 2 1 6.9
assay format 1 5 5.4
single protein format 1 2 6.9
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine